MedTrace Logo

Pilot Study to Evaluate the Long-term Chronic Care of Patients Who Could or do Utilize an Osseointegrated Device (OID)

NCT04899037 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-10-28

No results posted yet for this study

Summary

The primary objective of the study is to evaluate OID hearing intervention on cognition among patients who could vs. do utilize an OID. We will also evaluate the long-term effects of OID use on secondary outcomes measures (hearing performance, quality-of-life, social interaction, communication, physical functioning, etc)

Conditions

  • Hearing Loss, Conductive
  • Hearing Loss, Mixed
  • Deafness, Unilateral

Interventions

OTHER

No intervention

This is an observational study of participants that either choose or not choose to utilize an OID. This is not an intervention prescribed study, however, participants may choose uptake of standard of care intervention and obtain and utilize an OID. An OID is an FDA-approved device commonly recommended to patients with conductive, mixed, or singled-sided hearing loss. There is no experimental intervention evaluated in this study.

Sponsors & Collaborators

  • Oticon Medical

    collaborator INDUSTRY

  • University of South Florida

    lead OTHER

Principal Investigators

  • Victoria Sanchez, Au.D, Ph.D · University of South Florida

  • Marsadi L Parliament, Au.D · University of South Florida

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-29
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04899037 on ClinicalTrials.gov